MicroRNA-181a reduces proliferation and migration induced by E2/NET by suppressing PGRMC1: a novel option to reduce breast cancer risk during MHT?

PURPOSE: Clinical studies suggest that estradiol combined with norethisterone (E2/NET) may increase breast cancer risk, and PGRMC1 plays a crucial function in this process. According to previous research, we demonstrated that E2/NET stimulated the proliferation of PGRMC1-overexpressing breast cancer (BC) cells. This in vitro study aimed to investigate the mechanism of microRNA-181a's anti-tumor effects on PGRMC1-overexpressing BC cells treated with E2/NET. METHODS: Stable PGRMC1-overexpressing MCF7 and T47D breast cancer cell models were established to analyze cell viability, cell proliferation, colony formation, and cell migration, to characterize miR-181a's anti-tumor effects on BC cells with E2/NET exposure. qRT-PCR and Western blot were performed to measure the expression of PGRMC1, PGRMC2, G3BP2, Pairbp1, NF-kB, and BAX at gene and protein levels. Luciferase reporter assays were performed to evaluate miR-181a binding to 3'UTR of PGRMC2 and G3BP2. RESULTS: Overexpression of miR-181a significantly reduced PGRMC1-overexpressing MCF7 cell viability, proliferation, and migration. Substantially decreased gene expression of PGRMC1, PGRMC2, G3BP2, Pairbp1, and NF-kB, and increased BAX in miR-181a-treated cells. MiR-181a inhibited PGRMC1 signaling through directly targeting PGRMC2 and G3BP2 and upregulating pro-apoptotic BAX. CONCLUSION: We reported evidence that miR-181a reduces the PGRMC1-overexpressing cell viability and upregulates pro-apoptotic BAX expression. MiR-181a can inhibit E2 combined with NET-induced PGRMC1, PGRMC2, and G3BP2 complex, thereby reducing the proliferation and migration effect of breast cancer cells treated with E2/NET.

Authors

Institutions

Publication Details

Journal
Gynecological Endocrinology
Published
2026-11-16
DOI
https://doi.org/10.1080/09513590.2026.2760011
Primary Topic
MicroRNA in disease regulation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

MicroRNA-181a reduces proliferation and migration induced by E2/NET by suppressing PGRMC1: a novel option to reduce breast cancer risk during MHT?

Alfred O. Mueck, Yuwei Guan, Xiangyan Ruan, Yuejiao Wang et al.
2 links
Gynecological Endocrinology
MicroRNA in disease regulation
article

MicroRNA-181a reduces proliferation and migration induced by E2/NET by suppressing PGRMC1: a novel option to reduce breast cancer risk during MHT?

Alfred O. Mueck, Yuwei Guan, Xiangyan Ruan, Yuejiao Wang, Muqing Gu, Yun Wei
article en

Abstract

PURPOSE: Clinical studies suggest that estradiol combined with norethisterone (E2/NET) may increase breast cancer risk, and PGRMC1 plays a crucial function in this process. According to previous research, we demonstrated that E2/NET stimulated the proliferation of PGRMC1-overexpressing breast cancer (BC) cells. This in vitro study aimed to investigate the mechanism of microRNA-181a's anti-tumor effects on PGRMC1-overexpressing BC cells treated with E2/NET. METHODS: Stable PGRMC1-overexpressing MCF7 and T47D breast cancer cell models were established to analyze cell viability, cell proliferation, colony formation, and cell migration, to characterize miR-181a's anti-tumor effects on BC cells with E2/NET exposure. qRT-PCR and Western blot were performed to measure the expression of PGRMC1, PGRMC2, G3BP2, Pairbp1, NF-kB, and BAX at gene and protein levels. Luciferase reporter assays were performed to evaluate miR-181a binding to 3'UTR of PGRMC2 and G3BP2. RESULTS: Overexpression of miR-181a significantly reduced PGRMC1-overexpressing MCF7 cell viability, proliferation, and migration. Substantially decreased gene expression of PGRMC1, PGRMC2, G3BP2, Pairbp1, and NF-kB, and increased BAX in miR-181a-treated cells. MiR-181a inhibited PGRMC1 signaling through directly targeting PGRMC2 and G3BP2 and upregulating pro-apoptotic BAX. CONCLUSION: We reported evidence that miR-181a reduces the PGRMC1-overexpressing cell viability and upregulates pro-apoptotic BAX expression. MiR-181a can inhibit E2 combined with NET-induced PGRMC1, PGRMC2, and G3BP2 complex, thereby reducing the proliferation and migration effect of breast cancer cells treated with E2/NET.

Gynecological EndocrinologyVol. 42(1)
Capital Medical University (CN), Beijing Obstetrics and Gynecology Hospital (CN), State Key Laboratory of Chemical Resource Engineering (CN), Beijing University of Chemical Technology (CN), University of Tübingen (DE)
Beijing Nova Program
Good health and well-being
MicroRNA in disease regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon